本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Corvus Pharmaceuticals, Inc.

9.05
+0.28003.19%
成交量:32.10万
成交额:291.39万
市值:6.76亿
市盈率:-16.20
高:9.24
开:8.82
低:8.72
收:8.77
52周最高:9.55
52周最低:2.54
股本:7,468.19万
流通股本:5,735.63万
量比:1.20
换手率:0.56%
股息:- -
股息率:- -
每股收益(TTM):-0.5587
每股收益(LYR):-1.0214
净资产收益率:-35.82%
总资产收益率:-34.87%
市净率:9.42
市盈率(LYR):-8.86

数据加载中...

2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/01

重要事件披露

Form 8-K - Current report
2024/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

重要事件披露

Form 8-K - Current report
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/07

重要事件披露

Form 8-K - Current report
2023/08/08

重要事件披露

Form 8-K - Current report